Inactive Instrument

Iconovo AB (publ) Share Price Nasdaq Stockholm

Equities

SE0010868943

Medical Equipment, Supplies & Distribution

Financials

Sales 2024 * 52.65M 4.9M 386M Sales 2025 * 76.4M 7.11M 560M Capitalization 181M 16.81M 1.33B
Net income 2024 * -21M -1.95M -154M Net income 2025 * -25M -2.33M -183M EV / Sales 2024 * 2.7 x
Net cash position 2024 * 38.6M 3.59M 283M Net cash position 2025 * - 0 0 EV / Sales 2025 * 2.36 x
P/E ratio 2024 *
-5.68 x
P/E ratio 2025 *
-6.88 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 62.44%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 47 13/04/20
Founder 60 31/12/12
Director of Finance/CFO 61 31/03/23
Members of the board TitleAgeSince
Founder 63 31/12/12
Chairman 65 30/04/21
Director/Board Member 58 31/12/20
More insiders
Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Company’s device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.
More about the company